Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Article
PubMed
Google Scholar
Reports based on data of National Cancer Registry. The Maria Sklodowska-Curie Memorial Cancer Center. Department of Epidemiology and Cancer Prevention, National Cancer Registry. http://onkologia.org.pl/k/baza-on-line/. Accessed 23 Oct 2018.
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094–108.
PubMed
Google Scholar
Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15(7):e268–78. https://doi.org/10.1016/S1470-2045(13)70591-6.
Article
PubMed
Google Scholar
Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer. 2010;17(4):1007–19.
PubMed
PubMed Central
Google Scholar
Moore K, Brewer MA. Endometrial Cancer: is this a new disease? Am Soc Clin Oncol Educ Book. 2017;37:435–42.
PubMed
Google Scholar
Dobrzycka B, Terlikowski SJ. Biomarkers as prognostic factors in endometrial cancer. Folia Histochem Cytobiol. 2010;48(3):319–22.
PubMed
Google Scholar
Shaw E, Farris M, McNeil J, Friedenreich C. Obesity and endometrial Cancer. Recent Results Cancer Res. 2016;208:107–36.
CAS
PubMed
Google Scholar
Linkov F, Goughnour SL, Ma T, Xu Z, Edwards RP, Lokshin AE, et al. Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss. Gynecol Oncol. 2017;147(1):133–8.
CAS
PubMed
PubMed Central
Google Scholar
Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomark Prev. 2011;20(5):971–7.
CAS
Google Scholar
Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, et al. Case-control study of inflammatory markers and the risk of endometrial cancer. Eur J Cancer Prev. 2013;22(4):374–9.
CAS
PubMed
Google Scholar
Busch EL, Crous-Bou M, Prescott J, Downing MJ, Rosner BA, Mutter GL, et al. Adiponectin, Leptin, and insulin-pathway receptors as endometrial Cancer subtyping markers. Horm Cancer. 2018;9(1):33–9.
CAS
PubMed
PubMed Central
Google Scholar
Nimptsch K, Pischon T. Obesity biomarkers, metabolism and risk of Cancer: an epidemiological perspective. Recent Results Cancer Res. 2016;208:199–217.
CAS
PubMed
Google Scholar
Liao C, Zhang D, Mungo C, Tompkins DA, Zeidan AM. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecol Oncol. 2014;135(1):163–71.
PubMed
PubMed Central
Google Scholar
Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers. 2014;29(1):e21–9. https://doi.org/10.5301/jbm.5000047.
Article
PubMed
Google Scholar
Zhang ZH, Su PY, Hao JH, Sun YH. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer. 2013;23(2):294–303.
PubMed
Google Scholar
Saito M, Sato Y, Watanabe J, Kuramoto H, Kaba S, Fukuda T. Angiogenic factors in normal endometrium and endometrial adenocarcinoma. Pathol Int. 2007;57(3):140–7.
CAS
PubMed
Google Scholar
Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. 2015;1347:45–51.
CAS
PubMed
Google Scholar
Dong Z, Chen J, Yang X, Zheng W, Wang L, Fang M, et al. Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition. Oncotarget. 2018;9(16):12705–17.
PubMed
PubMed Central
Google Scholar
Semenza GL. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene. 2013;32:4057–63.
CAS
PubMed
Google Scholar
Xu Y, Zhang Y, Wang Z, Chen N, Zhou J, Liu L. The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer: a meta-analysis. Medicine (Baltimore). 2017;96(37):e8063. https://doi.org/10.1097/MD.0000000000008063.
Article
CAS
Google Scholar
Garrett PE, Lasky FD, Meier KL. User protocol for evaluation of qualitative test performance: Approved guideline-Second edition. CLSI EP121-A2 2008. http://www.clsi.org. Accessed 11 Dec 2018.
WHO. Body mass index-BMI. https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. Accessed 17 Sept 2020.
World Cancer Research Fund International. http://www.wcrf.org/int/cancer-facts-figures/link-between-lifestyle-cancer-risk/cancers-linked-greater-body-fatness. Accessed 23 Oct 2018.
Daley-Brown D, Oprea-Ilies GM, Lee R, Pattillo R, Gonzalez-Perez RR. Molecular cues on obesity signals, tumor markers and endometrial cancer. Horm Mol Biol Clin Invest. 2015;21(1):89–106.
CAS
Google Scholar
Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial Cancer risk, prevention, and treatment. J Clin Oncol. 2016;34(35):4225–30.
CAS
PubMed
PubMed Central
Google Scholar
Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012;120(2 Pt 1):383–97.
PubMed
Google Scholar
Arem H, Irwin ML. Obesity and endometrial cancer survival: a systematic review. Int J Obes. 2013;37(5):634–9.
CAS
Google Scholar
McTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 2010;28(26):4074–80.
PubMed
PubMed Central
Google Scholar
Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114(1):121–7.
PubMed
Google Scholar
Mauland KK, Trovik J, Wik E, Raeder MB, Njolstad TS, Stefansson IM, et al. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. Br J Cancer. 2011;104(6):921–6.
CAS
PubMed
PubMed Central
Google Scholar
Papatla K, Huang M, Slomovitz B. The obese endometrial cancer patient: how do we effectively improve morbidity and mortality in this patient population? Ann Oncol. 2016;27(11):1988–94.
CAS
PubMed
Google Scholar
Nevadunsky NS, Van Arsdale A, Strickler HD, Moadel A, Kaur G, Levitt J, et al. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol. 2014;124(2 Pt 1):300–6.
PubMed
Google Scholar
Bruchim I, Sarfstein R, Werner H. The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches. Front Endocrinol (Lausanne). 2014;5:76. https://doi.org/10.3389/fendo.2014.00076.
Article
Google Scholar
Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer. 2011;104(1):51–9.
CAS
PubMed
Google Scholar
Borghi C, Indraccolo U, Scutiero G, Iannone P, Martinello R, Greco P, et al. Biomolecular basis related to inflammation in the pathogenesis of endometrial cancer. Eur Rev Med Pharmacol Sci. 2018;22(19):6294–9.
CAS
PubMed
Google Scholar
Dobrzycka B, Terlikowski SJ, Kwiatkowski M, Garbowicz M, Kinalski M, Chyczewski L. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer. Ginekol Pol. 2010;81:422–5.
PubMed
Google Scholar
Dobrzycka B, Mackowiak-Matejczyk B, Kinalski M, Terlikowski SJ. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma. Gynecol Oncol. 2013;128(3):454–60.
CAS
PubMed
Google Scholar
Lorbeer R, Baumeister SE, Dörr M, Nauck M, Grotevendt A, Schlesinger S, et al. Angiopoietin-2, its soluble receptor Tie-2, and metabolic syndrome components in a population-based sample. Obesity (Silver Spring). 2016;24(10):2038–41.
CAS
Google Scholar
Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes. 2005;29(11):1308–14.
CAS
Google Scholar
Kaess BM, Pedley A, Massaro JM, Larson MG, Corsini E, Hoffmann U, et al. Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham heart study. J Clin Endocrinol Metab. 2012;97(3):987–94.
CAS
PubMed
Google Scholar
David S, Kümpers P, Lukasz A, Kielstein JT, Haller H, Fliser D. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin. J Hypertens. 2009;27(8):1641–7.
CAS
PubMed
Google Scholar
Wang Q, Lash GE. Angiopoietin 2 in placentation and tumor biology: the yin and yang of vascular biology. Placenta. 2017;56:73–8.
CAS
PubMed
Google Scholar
Cullberg KB, Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects. Obesity (Silver Spring). 2013;21(3):454–60.
CAS
Google Scholar
Cao D, Hou M, Guan YS, Jiang M, Yang Y, Gou HF. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer. 2009;9:432. https://doi.org/10.1186/1471-2407-9-432.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coelho AL, Gomes MP, Catarino RJ, Rolfo C, Medeiros RM, Araújo AM. CSF-1 and Ang-2 serum levels - prognostic and diagnostic partners in non-small cell lung cancer. ESMO Open. 2018;3(5):e000349. https://doi.org/10.1136/esmoopen-2018-000349.
Article
PubMed
PubMed Central
Google Scholar
Barron GA, Goua M, Wahle KWJ, Bermano G. Circulating levels of angiogenesis-related growth factors in breast cancer: a study to profile proteins responsible for tubule formation. Oncol Rep. 2017;38(3):1886–94.
CAS
PubMed
Google Scholar
Yang P, Chen N, Yang D, Crane J, Yang S, Wang H, et al. The ratio of serum Angiopoietin-1 to Angiopoietin-2 in patients with cervical cancer is a valuable diagnostic and prognostic biomarker. PeerJ. 2017;5:e3387. https://doi.org/10.7717/peerj.3387.
Article
CAS
PubMed
PubMed Central
Google Scholar
Atesoglu EB, Tarkun P, Mehtap O, Demirsoy ET, Atalay F, Maden M, et al. Serum Angiopoietin levels are different in acute and chronic myeloid neoplasms: Angiopoietins do not only regulate tumor angiogenesis. Indian J Hematol Blood Transfus. 2016;32(2):162–7.
PubMed
Google Scholar
Wang ZQ, Sun XL, Su HL, Liu XF, Xuan YJ, Yu SQ. Association between serum angiopoietin-2 concentration and clinicopathological parameters in patients with colorectal cancer. Genet Mol Res. 2015;14(4):15547–52.
CAS
PubMed
Google Scholar
Gathirua-Mwangi WG, Song Y, Monahan PO, Champion VL, Zollinger TW. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III. Int J Cancer. 2018;143(3):535–42.
CAS
PubMed
PubMed Central
Google Scholar